Cargando…

Metformin, arterial contrast and acute kidney injury

Detalles Bibliográficos
Autores principales:	Amos, Lal, Nirmal, J. Kaur, Nitin, Trivedi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mattioli 1885 2019
Materias:	E-Letters: Comments and Responses
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776214/ https://www.ncbi.nlm.nih.gov/pubmed/31125020 http://dx.doi.org/10.23750/abm.v90i2.8371

Ejemplares similares

Workplace Safety: Both Physical and Emotional
por: Lal, Amos, et al.
Publicado: (2021)

Dasatinib induced pleuro-pericardial effusion
por: Mishra, Ajay Kumar, et al.
Publicado: (2020)

Comment on Flory et al. Reports of Lactic Acidosis Attributed to Metformin, 2015–2018. Diabetes Care 2020;43:244–246
por: Brand, Kerstin
Publicado: (2020)

Comment on Moore et al. Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin. Diabetes Care 2013;36:2981–2987
por: Goodarzi, Mark O.
Publicado: (2014)

Comment on Vistisen et al. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes. Diabetes Care 2021;44:901–907
por: Østergaard, Helena Bleken, et al.
Publicado: (2021)

Response to Comment on Vistisen et al. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes. Diabetes Care 2021;44:901–907
por: Vistisen, Dorte, et al.
Publicado: (2021)

Spinal Cord Injury Without Radiological Abnormalities and the importance of Magnetic Resonance: not only diagnostic, but also predictive!
por: Martínez-Pérez, Rafael, et al.
Publicado: (2020)

Response to Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383–390
por: Niewczas, Monika A., et al.
Publicado: (2017)

Comment on: TODAY Study Group. Effects of Metformin, Metformin Plus Rosiglitazone, and Metformin Plus Lifestyle on Insulin Sensitivity and β-Cell Function in TODAY. Diabetes Care 2013;36:1749–1757
por: Baldi, James C., et al.
Publicado: (2013)

Response to Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912–1920
por: Nauck, Michael A., et al.
Publicado: (2020)

Response to Comment on Dawed et al. Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673–2682
por: Dawed, Adem Y., et al.
Publicado: (2022)

Reply to 'The link between pulmonary hypertension and adverse renal transplant outcome may be renal venous hypertension'
por: Solanki, Sohan Lal, et al.
Publicado: (2018)

Reply to: Society of Onco-Anaesthesia and Perioperative Care advisory on anaesthesia in COVID-19: What is lacking?
por: Solanki, Sohan Lal, et al.
Publicado: (2020)

Response to Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670
por: Sarkar, Gayatri, et al.
Publicado: (2014)

Response to Comment on Lacy et al. Long-term Glycemic Control and Dementia Risk in Type 1 Diabetes. Diabetes Care 2018;41:2339–2345
por: Lacy, Mary E., et al.
Publicado: (2019)

Comment on Desai et al. Health Care Utilization and Burden of Diabetic Ketoacidosis in the U.S. Over the Past Decade: A Nationwide Analysis. Diabetes Care 2018;41:1631–1638
por: Galindo, Rodolfo J., et al.
Publicado: (2019)

Comment on Brethauer et al. Bariatric Surgery Improves the Metabolic Profile of Morbidly Obese Patients With Type 1 Diabetes. Diabetes Care 2014;37:e51–e52
por: Middelbeek, Roeland J.W., et al.
Publicado: (2014)

Response to Comment on Lee et al. Relation of Change or Substitution of Low- and No-Calorie Sweetened Beverages With Cardiometabolic Outcomes: A Systematic Review and Meta-analysis of Prospective Cohort Studies. Diabetes Care 2022;45:1917–1930
por: Lee, Jennifer J., et al.
Publicado: (2023)

Response to Comment on Kelly et al. Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes. Diabetes Care 2018;41:120–127
por: Kelly, Clare B., et al.
Publicado: (2018)

Response to Comment on Laiteerapong et al. The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study). Diabetes Care 2019;42:416–426
por: Laiteerapong, Neda, et al.
Publicado: (2019)

Comment on Satin et al. “Take Me To Your Leader”: An Electrophysiological Appraisal of the Role of Hub Cells in Pancreatic Islets. Diabetes 2020;69:830–836
por: Rutter, Guy A., et al.
Publicado: (2020)

Comment on Harlan. Islet Transplantation for Hypoglycemia Unawareness/Severe Hypoglycemia: Caveat Emptor. Diabetes Care 2016;39:1072–1074
por: Hering, Bernhard J., et al.
Publicado: (2017)

Response to Comment on So et al. Autoantibody Reversion: Changing Risk Categories in Multiple-Autoantibody–Positive Individuals. Diabetes Care 2020;43:913–917
por: So, Michelle, et al.
Publicado: (2020)

Response to Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264–270
por: Rickels, Michael R., et al.
Publicado: (2016)

Response to Comment on Pathak et al. Severe Hypoglycemia Requiring Medical Intervention in a Large Cohort of Adults With Diabetes Receiving Care in U.S. Integrated Health Care Delivery Systems: 2005–2011. Diabetes Care 2016;39:363–370
por: Pathak, Ram D., et al.
Publicado: (2017)

Response to Comment on Lee et al. Multicenter, Head-to-Head, Real-World Validation Study of Seven Automated Artificial Intelligence Diabetic Retinopathy Screening Systems. Diabetes Care 2021;44:1168–1175
por: Lee, Aaron Y., et al.
Publicado: (2021)

Response to Comment on American Diabetes Association. Approaches to Glycemic Treatment. Sec. 7. In Standards of Medical Care in Diabetes—2016. Diabetes Care 2016;39(Suppl. 1):S52–S59
por: Herman, William H., et al.
Publicado: (2016)

Response to Comment on Nunley et al. Clinically Relevant Cognitive Impairment in Middle-Aged Adults With Childhood-Onset Type 1 Diabetes. Diabetes Care 2015;38:1768–1776
por: Nunley, Karen A., et al.
Publicado: (2016)

Response to Comment on Hempe et al. The Hemoglobin Glycation Index Identifies Subpopulations With Harms or Benefits From Intensive Treatment in the ACCORD Trial. Diabetes Care 2015;38:1067–1074
por: Hempe, James M., et al.
Publicado: (2015)

Response to Comment on O’Connor et al. Randomized Trial of Telephone Outreach to Improve Medication Adherence and Metabolic Control in Adults With Diabetes. Diabetes Care 2014;37:3317–3324
por: O’Connor, Patrick J., et al.
Publicado: (2015)

Response to Comment on Doyle et al. Closed-Loop Artificial Pancreas Systems: Engineering the Algorithms. Diabetes Care 2014;37:1191–1197
por: Doyle, Francis J., et al.
Publicado: (2014)

Response to Comment on Neeland et al. The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial. Diabetes Care 2020;43:3007–3015
por: Neeland, Ian J., et al.
Publicado: (2021)

Response to Comments on Brethauer et al. Bariatric Surgery Improves the Metabolic Profile of Morbidly Obese Patients With Type 1 Diabetes. Diabetes Care 2014;37:e51–e52
por: Kirwan, John P., et al.
Publicado: (2014)

Response to Comment on Almurdhi et al. Reduced Lower-Limb Muscle Strength and Volume in Patients With Type 2 Diabetes in Relation to Neuropathy, Intramuscular Fat, and Vitamin D Levels. Diabetes Care 2016;39:441–447
por: Almurdhi, Monirah M., et al.
Publicado: (2016)

Response to Comment on Misra et al. Homozygous Hypomorphic HNF1A Alleles Are a Novel Cause of Young-Onset Diabetes and Result in Sulfonylurea-Sensitive Diabetes. Diabetes Care 2020;43:909–912
por: Misra, Shivani, et al.
Publicado: (2020)

Response to Comment on Home et al. Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges? Diabetes Care 2014;37:1499–1508
por: Home, Philip, et al.
Publicado: (2014)

Increased Reporting of Immune Checkpoint Inhibitor–Associated Diabetes
por: Wright, Jordan J., et al.
Publicado: (2018)

Response to Comment on Elliott et al. Prevalence and Prognosis of Unrecognized Myocardial Infarction in Asymptomatic Patients With Diabetes: A Two-Center Study With Up to 5 Years of Follow-up. Diabetes Care 2019;42:1290–1296
por: Elliott, Michael D., et al.
Publicado: (2019)

Response to Comment on Pinsker et al. Randomized Crossover Comparison of Personalized MPC and PID Control Algorithms for the Artificial Pancreas. Diabetes Care 2016;39:1135–1142
por: Pinsker, Jordan E., et al.
Publicado: (2017)

Response to Comment on Hofer et al. International Comparison of Smoking and Metabolic Control in Patients With Type 1 Diabetes. Diabetes Care 2016;39:e177–e178
por: Hofer, Sabine E., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uncu514nc8ooe434jago03p7je